United States: CMS Releases CY 2016 OPPS Proposed Rule With Updates To Two-Midnight Rule And Other IPPS Proposals

On July 1, 2015, the Centers for Medicare and Medicaid Services (CMS) released the calendar year (CY) 2016 outpatient prospective payment system (OPPS)/ambulatory surgical center (ASC) payment system proposed rule that updates payment policies and rates for hospital outpatient departments and ASCs. The proposed rule also includes certain proposals relating to the hospital inpatient prospective payment system (IPPS), including changes to the two-midnight rule.

Comments on the proposed rule are due by August 31, 2015, and a final rule is expected in November 2015. If adopted, the changes will take effect January 1, 2016.

Highlights of the proposed rule are noted below.

Key Changes Impacting Inpatient Stays

"Case-by-Case" Exception to the Two-Midnight Rule

CMS proposes to revise its two-midnight policy regarding when hospital stays are appropriate for payment under Medicare Part A.

CMS established its two-midnight policy in the fiscal year (FY) 2014 IPPS final rule. The two-midnight rule provides that a hospital inpatient admission generally is considered reasonable and necessary if a physician or other qualified practitioner orders such admission based on the expectation that the beneficiary's length of stay will exceed two midnights or if the beneficiary requires an inpatient-only procedure. Hospital stays expected to span less than two midnights presumptively are considered outpatient cases and, therefore, not appropriate for Part A payment.

The proposed rule does not change the two-midnight policy for hospital stays that are expected to cross two midnights or longer. For stays expected to last less than two midnights, CMS acknowledged stakeholder concerns that the two-midnight rule removes physician judgment from the decision to admit a patient for inpatient hospital services. Although CMS will continue to adhere to the two-midnight benchmark, the proposed rule would allow Part A payment on a "case-by-case basis" under the existing "rare and unusual" exceptions policy for inpatient admissions that do not satisfy the two-midnight benchmark provided that documentation in the beneficiary's medical record supports the admitting physician's determination that the patient requires inpatient hospital care despite an expected length of stay that is less than two midnights. CMS further reiterated that inpatient admissions for minor surgical procedures or other treatments expected to require hospitalization for only a few hours would be considered "rare and unusual." According to CMS, these rare and unusual cases will be a priority for medical review organizations.

CMS considers the following factors to be relevant in determining whether a patient stay that is expected to be less than two midnights is nonetheless appropriate for Part A payment:

  • The severity of the signs and symptoms the patient exhibits;
  • The medical predictability of something adverse happening to the patient; and
  • The need for diagnostic studies that are appropriately outpatient services (the performance of which ordinarily would not require the patient to remain in the hospital for 24 hours).

QIO Review of Inpatient Stays

CMS also announced that by October 1, 2015, Quality Improvement Organizations (QIOs) will take over first-line medical reviews of short inpatient stays from Medicare Administrative Contractors in order to foster a more collaborative approach to education and enforcement. The QIOs are expected to better educate hospitals and physicians about claims denied under the two-midnight rule. This change will take effect regardless of whether the other proposed changes to the two-midnight rule are finalized. Hospitals that are found to consistently have high denial rates will be referred to the appropriate recovery audit contractor for further payment audits.

Key Changes Impacting OPPS/ASC Payments

The proposed rule also includes payment rate adjustments, new requirements for computed tomography (CT) payment, and changes in quality measurement and reporting for the OPPS. In addition, CMS adopted policy changes consistent with its stated goal to make OPPS payments for all services paid under the OPPS more consistent with those of a prospective payment system and less like a fee-for-service payment system.

Restructuring and Consolidation of APCs

In the CY 2014 OPPS/ASC final rule, CMS finalized a comprehensive payment policy that packages payment for adjunctive and secondary items, services, and procedures, and beginning in CY 2015, establishes 25 comprehensive ambulatory payment classifications (C-APCs). This results in a single prospective payment for each of the primary comprehensive services based on the costs of all reported services at the claim level. For CY 2016, CMS proposed nine new C-APCs to be paid under the existing C-APC payment policy: ENT procedures, intraocular procedures, gynecology procedures,

laparoscopy (2), musculoskeletal procedures, urological procedures and related services, ancillary outpatient services when a patient expires, and comprehensive observation services.

CMS also proposes to restructure existing APCs in nine clinical families:

  • Diagnostic tests and related services
  • Endoscopy procedures
  • Gastrointestinal procedures
  • Imaging services
  • Incision and drainage and excision/biopsy procedures
  • Orthopedic procedures
  • Skin-related procedures
  • Urology and related procedures
  • Vascular procedures

Expansion of Ancillary Services Packaging

In the CY 2015 OPPS/ASC final rule, CMS conditionally packaged payment for ancillary services assigned to APCs with a geometric mean cost of less than or equal to $100. In the proposed rule, CMS reiterated that conditional packaging may be appropriate for more costly ancillary services given the context in which the service is performed. Thus, for CY 2016, CMS proposes to expand the set of conditionally packaged ancillary services to include services in three APCs – Level 4 Minor Procedures, Level 3 Pathology, and Level 4 Pathology – each of which has a geometric mean cost of more than $100. However, to avoid packaging certain high-cost pathology services with lower-cost and non-primary services such as low-cost imaging services, the Level 3 and Level 4 pathology services will be packaged only when they are billed with a surgical service.

Packaging of Clinical Diagnostic Laboratory Tests

Under CMS's current policy, certain clinical diagnostic tests are packaged in the OPPS payment system as "integral, ancillary, supportive, dependent, or adjunctive" to the primary service or services provided in the hospital outpatient setting on the same date of service as the laboratory test. Under the proposed rule, CMS plans to expand this policy and consider laboratory tests provided during the same outpatient stay (rather than specifically provided on the same date of service as the primary service) as "integral, ancillary, supportive, dependent, or adjunctive" to a primary service or services, except when a laboratory test is ordered for a different purpose and by a different practitioner than the practitioner who ordered the other OPPS service(s).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions